Categories: Market Research

Clinical Trial Management System (CTMS) Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Clinical Trial Management System (CTMS) Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Clinical Trial Management System (CTMS) Market:

https://www.thebusinessresearchcompany.com/report/clinical-trial-management-system-ctms-global-market-report

According to The Business Research Company’s Clinical Trial Management System (CTMS) Global Market Report 2024, The clinical trial management system (ctms) market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.41 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to increasing clinical trial complexity, rise in global clinical trials, stringent regulatory compliance, growing focus on patient-centric trials, increasing outsourcing of clinical trials..

The clinical trial management system (ctms) market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to emphasis on real-time data access, integration with electronic health records (ehrs), rise in virtual and decentralized trials, focus on risk-based monitoring, advancements in analytics and ai.. Major trends in the forecast period include focus on regulatory compliance and data security, rise of adaptive clinical trial designs, collaborative platforms for stakeholder engagement, remote site monitoring and management, evolving data standards and interoperability..

The increasing number of decentralized clinical trials is expected to propel the growth of the clinical trial management system (CTMS) market going forward. Decentralized clinical trials (DCTs) refer to studies that utilize telemedicine and local healthcare services to minimize or remove patients’ need to visit hospital-based trial locations, in contrast to the traditional clinical trial framework. A clinical trial management system (CTMS) monitors recruitment and participant activities, providing detailed oversight and reporting throughout decentralized trials. For instance, in December 2021, according to Clinical Trials Arena, a UK-based online publication focused on clinical trials and research, the number of trials incorporating decentralized and virtual components is expected to reach approximately 1,300 trials in 2022, with a 28% increase compared to 1000 trials in 2021. Therefore, the increasing number of decentralized clinical trials will drive the growth of the clinical trial management system (CTMS) market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=13147&type=smp

The clinical trial management system (ctms) market covered in this report is segmented –

1) By System Type: Enterprise Clinical Trial Management System, On-Site Clinical Trial Management System

2) By Component: Software, Service, Hardware

3) By Delivery: Web-based (On-demand), Licensed Enterprise (On-premises), Cloud-based (SaaS)

4) By End User: Large Pharma-biotech Companies, CROs, Medical Device Manufacturers, Small And Mid-sized Pharma-biotech Companies, Other End Users

Major companies operating in the clinical trial management system (CTMS) are innovating new technological platforms, such as Software as a Service (SaaS) solutions integrated with artificial intelligence, to hasten the development of drugs. A SaaS-based Clinical Trial Management System (CTMS) is a cloud-hosted software platform that assists in efficiently managing and overseeing various aspects of clinical trials, making it accessible from anywhere with an internet connection and reducing the need for local software installation and maintenance. For instance, in June 2023, Saama Technologies, Inc., a US-based provider of clinical development software and services, launched a unified platform of SaaS-based products that complement its existing artificial intelligence and machine learning-based solutions, facilitating faster clinical development and commercialization. The platform automates key clinical trial management processes, reducing query generation times by up to 90% and achieving significant time savings in study data transformation and analysis. It offers a comprehensive view of trial operations and patient progress in a single location.

The clinical trial management system (ctms) market report table of contents includes:

Executive Summary
Clinical Trial Management System (CTMS) Market Characteristics
Clinical Trial Management System (CTMS) Market Trends And Strategies
Clinical Trial Management System (CTMS) Market – Macro Economic Scenario
Global Clinical Trial Management System (CTMS) Market Size and Growth

Global Clinical Trial Management System (CTMS) Market Competitive Benchmarking
Global Clinical Trial Management System (CTMS) Market Competitive Dashboard
Key Mergers And Acquisitions In The Clinical Trial Management System (CTMS) Market
Clinical Trial Management System (CTMS) Market Future Outlook and Potential Analysis
Appendix

Top Major Players: